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ABSTRACT  Although  monoclonal  in origin, mammary tumors acquire a marked heterogeneity 
of cell phenotypes, including a mixture of steroid hormone-sensitive cells and insensitive  cells. 
We  describe  here  long-term  studies  on  the  effects  of  androgen  withdrawal  on  cloned 
androgen-responsive  $115  mouse  mammary  tumor  cells  as  a  model  system  to  investigate 
mechanisms  by which  tumor cells  lose their steroid  sensitivity.  In the prolonged  absence of 
androgen, the cells  lost hormone-sensitive  parameters  reproducibly,  including  loss of prolif- 
erative response,  saturation density response, cell morphology response,  and mouse mammary 
tumor virus  long terminal  repeat  (MMTV-LTR)-related  RNA.  These experiments  have  dem- 
onstrated that when deprived  of hormone  in the long term, a clone of responsive cells  gives 
rise  reproducibly  to  a  population  of  unresponsive  cells  in  an  ordered  series  of phenotypic 
changes.  At the time when the cells  lost  all  androgen  response  in  terms of cell  biology and 
MMTV-LTR-RNA, increased methylation of MMTV-LTR sequences in the DNA was detected. 
Thereafter recovery of androgen sensitivity  has not been achieved in any of these parameters. 
The possible  role of de novo  DNA methylation  in the progression  to androgen autonomy of 
$115 cells  is discussed. 
Manipulation of the steroid environment affects breast tumor 
growth in  many species (26,  29) but  only on  a  temporary 
basis, and even in rodents, where effects are greatest, it never 
eliminates the tumor completely (19).  In man, 30% of breast 
cancers regress after endocrine therapy, and a recent approach 
has  been  to  select likely hormone-sensitive tumors on  the 
basis of estrogen and progesterone receptor levels (9).  How- 
ever,  possession  of receptors  is  not  the  sole  criterion  for 
response  to  therapy  and  in  any  case  regression  is  at  best 
temporary, to be followed by hormone-independent tumors 
and metastatic disease. This progression to hormone insensi- 
tivity is a major clinical problem. 
Tumors are composed of mixed populations of cells that 
have a wide range of phenotypes. Cells obtained from individ- 
ual  rodent  mammary tumors  differ not  only  in  hormone 
receptors (35)  and  hormone-dependent  growth  (8,  39)  but 
also in immunological properties (24),  transplantability (36), 
metastatic capability (18), tumorigenicity (38), drug resistance 
(23),  growth rate (11),  karyotype (11,  22),  mouse mammary 
tumor virus (MMTV) 1 expression (35),  and MMTV proviral 
Abbreviations used in this paper.  +A and -A, androgen responsive 
and unresponsive, respectively;  DC, dextran-charcoal; DME, Dulbec- 
copies (32).  It is now accepted that the origin of mammary 
tumors is monoclonal (10),  but how such diversity arises is 
still unknown. The mechanism could involve either genotypic 
or phenotypic change. Evidence for a genotypic mechanism, 
involving mutation followed by cell selection, has been im- 
plied from karyotype studies (11,  22, 25) and from changes 
in exogenous integrated MMTV (32).  A  phenotypic mecha- 
nism would involve stable alteration in the program of gene 
expression and could result from either selection ofphenotyp- 
ically altered cells (e.g.,  hormone-unresponsive cells growing 
selectively  under  low  hormone  conditions)  or  universal 
change throughout the whole cell population. Little attention 
has been paid to this latter possibility. 
An excellent model system for studies on the progression 
of tumor cells to steroid autonomy is the androgen-dependent 
Shionogi 115 mouse mammary carcinoma. This tumor shows 
androgen-dependent growth  properties,  and  after androgen 
removal, manifests temporary regression followed by growth 
of androgen-independent  tumors  (31).  Use  of cloned  cells 
co's Modified Eagle's medium;  FCS, fetal calf serum; LTR,  long 
terminal repeat; MMTV, mouse mammary  tumor virus; +T and -T, 
in the presence and absence of testosterone, respectively. 
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to study the phenomenon  in  more  detail. Cloned  androgen- 
responsive S 115 cells exhibit a  positive proliferative response 
to  androgens  when  maintained  as stocks in  the presence of 
testosterone  (+A  cells)  (37).  Removal  of testosterone  (-T) 
results within  1-3 d  in a  50%  reduction in growth rate (27, 
28) and a total change of all cells from fibroblastic to epithelial 
morphology  (44). The cells develop an increased dependence 
on anchorage to the substrate for growth (39, 42), an increased 
density  regulation  (43),  lost  ability  to  grow  in  suspension 
culture  (44),  increased  sensitivity to  various  growth  stimuli 
(43), and an alteration in cytoskeletal structure (5). However, 
after several weeks of culture in the absence of testosterone, 
the  cells  became  unresponsive  to  androgens  (-A  cells)  in 
terms  of cell  growth  rate,  cell  morphology,  and  growth  in 
suspension (39, 43, 44). 
Since these dramatic  hormone-regulated  alterations in cell 
behavior  parallel  those  changes  seen  in  transformation,  we 
have  suggested  that  some  transforming  gene  could  be  in- 
volved, for example, associated with MMTV  (6, 42). MMTV 
is present in  the DNA  of S 115  cells and  no gross genotypic 
change  in  proviral  copies  accompanies  the  transition  from 
hormone-responsive  (+A)  to  unresponsive  (-A)  state  (6). 
However, RNA  from MMTV  is present only in +A  and not 
-A  cells,  and  the  loss of MMTV  RNA  is  accompanied  by 
increased  methylation  in  proviral  copies  in  the  DNA  (6). 
Thus,  in these cloned cells, phenotypic  changes occur in the 
transition to steroid autonomy  which are not associated with 
gross genotypic alteration. In this report, we describe detailed 
time courses of the phenotypic changes during transition from 
androgen-responsive  (+A)  to  androgen-unresponsive  (-A) 
state  in  terms  of loss  of proliferative  response,  loss  of cell 
morphological response, loss of MMTV-RNA,  and increased 
methylation  of certain  MMTV  sequences in  the  DNA.  We 
report attempts to recover hormone  sensitivity in insensitive 
cells. 
MATERIALS  AND  METHODS 
Nomenclature of S115  Cells:  Stock Sl15 cells are a cloned cell 
line maintained in androgen that exhibit a positive proliferative  response to 
androgen. These cells are called +A cells. Long-term maintenance of such cells 
in  the absence of androgen results  in  the cells  becoming unresponsive to 
androgens, and such cells  are then called  -A ceUs. Experimental growth of 
Sl I5 cells in the presence or absence of testosterone is indicated as +T or -T, 
respectively. 
Culture of Stock SI15 Cells:  Stock +A Sll5  cells were grown as 
monolayer cultures in Dulbecco's modified Eagle's  medium (DME) supple- 
mented with 2%  dextran-charcoal-treated fetal  calf serum (DC-FCS)  (FCS 
from Gibeo-Biocult,  Glasgow, Scotland), 40 mM HEPES buffer (Sigma Chem- 
ical Co., Poole, England),  and 3.5 ×  10-* testosterone. DC-treated serum was 
used in  all  cultures and this treatment has been described previously  (7). 
Testosterone  (Steraloids Ltd., Croydon, England) was dissolved in ethanol and 
added such that the final concentration was <0.01% ethanol in culture medium. 
Cells were seeded at 0. l ×  10  s eells/ml in 45-ml aliquots in 15-cm plastic tissue 
culture dishes (Nunc, Denmark) and placed in a  humidified atmosphere of 
10% carbon dioxide in air at 37"C. 
Cells were subcultured at weekly intervals. Cells were suspended  by treatment 
in 5 ml of 0.06% trypsin/0.02% EDTA (pH 7.3) and added to 5 ml of culture 
medium. The cells were pelleted by centrifugation, resuspended in culture 
medium alone, counted on a haemocytometer, and replated as above. 
Cloned S115 Cells:  Asingleclonewasusedforalltheseexperiments. 
The clone ofS115 +A cells was selected as fulfilling the criteria: (a) it originated 
from a single cell, (b) it was morphologically  similar to the original population, 
(c) it exhibited a positive proliferative response to androgen, and (d) it possessed 
androgen receptors (3). 
Cells were subcultured until enough were available for experimental use and 
were then stored frozen in liquid nitrogen in aliquots of 3.5 ×  10  ~ cells in l ml 
of DME/10% FCS/10% dimethylsulphoxide  (Fisous Scientific Apparatus Ltd., 
Loughboruugh,  Leicestershire, England). 
Stock  Cultures  for Loss and  Recovery of Response Experi- 
ments:  At the start of each experiment, a  new vial of cells was thawed, 
which ensured that cells were always of the same clone and passage generation. 
Freshly thawed cells were grown for 2 wk as stock +A cultures and then some 
cells  were switched to medium lacking testosterone. For recovery of response, 
testosterone  was added back to the medium of some stocks. Culture conditions 
and medium were kept the same throughout except for the presence or absence 
of testosterone.  Cells were assayed  from these stock cultures for androgen- 
responsive growth at regular intervals. 
Cell Growth Experiments:  Cells were suspended from stock plates 
by treatment with 5 ml 0.06% trypsin/0.02% EDTA (pH 7.3), added to 5 ml 
DME/2% DC-FCS/40 mM HEPES buffer, and counted on a haemocytometer. 
Cells were added to the overall  required volume of medium DME/2% DC- 
FCS/40 mM HEPES buffer at a concentration of  0.1 x  10  ~  cells/ml and plated 
in monolayer in 5-ml aliquots into 5-cm plastic tissue culture dishes for 24 h. 
The medium was then changed so that some dishes contained testosterone and 
some did not. Culture medium was changed routinely every 3-4 d. 
Cell Counting:  Cells were counted after 24 h to give the plating density 
and subsequently at least four times in the presence and absence of  testosterone, 
usually after 2, 3, 4, 7, and 9 d. All cell counts were done on triplicate dishes 
and results were calculated as the mean + SE. 
Cells in monolayer were washed with saline in situ and lysed in 2 ml 0.01 
M HEPES buffer/l.5 mM MgClz plus four drops of Zaponin (Coulter Elec- 
tronics Ltd., Harpenden, England) for 5 min. The nuclei released were counted 
in  Isoton (Coulter Electronics  Ltd.) in  triplicate on a  model ZBI  Coulter 
Counter. 
Doubling time of the cells was calculated  from at least three early time 
points of a growth curve; the plot ofloglo (cell number) against time was linear 
and of the form y =mx + c. Doubling time was calculated as a function of  the 
slope, m (loglo2/m). The error on the slope, Sb was calculated by the standard 
statistical formula 
/~V--~r- yc)2  1  Sb=  52(X=~'~  n  - 2 
where y = actual y value, yc = estimated y value, x = actual x value, ~ = mean 
x value, and n = number of values for x and y. 
Preparation  of Cytoplasmic  RNA:  A  minimum of 3  x  15 cm 
dishes of  stock cells were used for each RNA preparation. Cells were washed in 
situ with PBS and harvested with a rubber policeman into ice-cold PBS. All 
procedures  were at 4°C from here on. The cells were spun down and resuspended 
in 0.1 M NaCI/0.001  M EDTA/0.01  M Tris HCI, pH 7.5/0.5%  Nonidet P-40 
(BDH Chemicals Ltd., Poole,  England).  The nuclei were then spun out, the 
supernatant was made I% in SDS (SERVA,  Feinbiochemica GmbH & Co., 
Heidelberg, Federal Republic of Germany) and extracted with phenobchloro- 
form  (phenol from  Fisons was  redisfilled  before use),  and  the  RNA  was 
precipitated in ethanol. 
Analysis of RNA by Northern Blotting:  RNA was subjected W 
electrophoresis  in 1.5% agarose-formaldehyde  gels (30) at 50 ~g total RNA per 
track. The RNA was transferred to nitrocellulose (Sartorius GmbH, G6ttingen, 
Federal Republic of  Germany) by blotting in 20 × standard saline-citrate buffer 
(SSC) and hybridized to 5 ×  l0  s epm. of 3aP-labeled probe per 10 ml. Hybrid- 
ization was in 1 x SSC, 10 × Denhardt's 0.1% SDS, 50 t~g/ml single-stranded 
calf  thymus DNA, and 10% dextran sulphate at 65°C for 16 h. The DNA probe 
was the cloned 1.4 kilobase pair Pst I fragment of MMTV containing the LTR 
region.  The fragment was cloned into the plasmid pAT  153 (a derivative  of 
pBR 322 [30]) (Biolabs, Beverly, MA) for preparation of large quantities and 
cut out and isolated from the plasmid before use as a probe. It was labeled with 
32p by nick translation (30). Blots were washed at a stringency of 0.2 × SSC, 
0.1% SDS for 1 h at 65°C and autoradiographed. 
Preparation of DNA:  A minimum of 2 x  15 cm dishes of stock cells 
were used for each DNA preparation. Cells were washed in situ with PBS, 
harvested with a rubber poficeman into PBS, spun down, and resuspended in 
l0 mM Tris/10 mM EDTA/100 pg/ml proteinase K (BDH Chemicals Ltd.) 
0.5%  SDS at 37"C for at least 4 h. The viscous solution was extracted with 
phenol-chloroform and the DNA was precipitated in ethanol. The DNA was 
dissolved in 10 mM Tris/10 mM EDTA/RNAase A 20 ~g/ml (Millipore Corp., 
Bedford, MA) at 37"(2 for 2 h. The solution was then made 0.2 M NaCl/0.1% 
SDS/100 #g/ml proteinase K and incubated another 2 h. The DNA was purified 
by phenol-chloroform extraction, precipitated in ethanol, and redissolved in 
sterile 1 mM Tris/1  mM EDTA pH 8 (33, 41). 
Methylation Patterns of DNA:  High molecular weight DNA was 
digested  with the restriction enzymes Hpa  II  or Msp I  (Biolabs)  and  the 
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transferred to nitrocellulose as described in detail elsewhere (30).  Blots were 
hybridized to 32P-labeled MMTV-LTR and washed as for the RNA analysis. 
RESULTS 
Cell Biology 
For analysis of loss of responsiveness, S 115 cells were kept 
long-term as stock cultures in the absence of testosterone. To 
study recovery of responsiveness, we grew some stock cells 
with testosterone added back to the medium. These cells were 
then assayed for androgen sensitivity at various time intervals 
by  removing an  aliquot  of cells  from  stock  cultures  and 
carrying out  growth  curves  over 9  d  in  the  presence and 
absence of testosterone. Analyses of these growth curves up 
to and including confluence have enabled us to study the time 
course of loss of androgen responsiveness in the S 115 cells in 
terms of both proliferative response and saturation density. 
Proliferative response has been calculated with respect to 
the doubling time of the cells in the short-term presence and 
absence of testosterone (Fig.  1).  Stock androgen-responsive 
+A cells grew much faster in the presence than in the absence 
of testosterone  (week  0,  Fig.  1).  After  2  wk  of androgen 
withdrawal in stock cultures, the rate of cell growth dropped, 
especially in the short-term presence of  testosterone. However, 
after 3 wk of androgen withdrawal, the rate of growth of stock 
cells increased in the short-term absence of testosterone, such 
that after 4 wk of androgen deprivation the stock cells grew 
faster  in  the  short-term  absence  than  in  the  presence  of 
testosterone. Thereafter, the rate of cell growth recovered in 
both the presence and absence of testosterone until after 9 wk 
of androgen  deprivation,  when  the  stock  cells  had  lost all 
proliferative response to androgen. 
Androgen responsiveness was also studied in terms of sat- 
uration  density  of the  cells.  We  followed  changes  in  the 
saturation density response over 34 wk of androgen depriva- 
tion in stock cultures both by plotting cell numbers per dish 
at  confluence  (Fig.  2)  and  by examining  cell  morphology 
under  the  microscope.  Observed  cell  morphology changes 
were reflected in the cell number per dish, and can be broadly 
divided into four stages.  (a) Stock androgen-responsive +A 
cells grew to much higher saturation densities in the presence 
than in the absence of testosterone (week 0,  Fig.  2).  In the 
15~ 
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WEEKS  IN  CULTURE MINUS TESTOSTERONE 
FIGURE  1  Changes in  the  rate of cell  proliferation in  monolayer 
culture in the short-term presence (H)  or absence (O----O) of 
testosterone, following increasing periods of long-term androgen 
withdrawal from  stock cultures.  Bars  represent the  error on  the 
doubling times (for calculation, see Materials and Methods). 
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FIGURE  2  Changes in the saturation density in monolayer culture 
in the short-term presence H)  or absence (r-I- -  -I-I) of tes- 
tosterone, following increasing periods of long-term androgen with- 
drawal from stock cultures. Each point represents the mean count 
of triplicate plates. Bars represent the standard error but no error 
bars are shown if variation was too low for visual display. 
presence  of testosterone,  the  ceils  at  confluence  were  of 
rounded fibroblastic morphology (for photograph, see refer- 
ence 44),  forming an uneven spread on the dish, with dense 
piles of ceils in some areas of the dish and empty patches in 
between. Removal of testosterone resulted in a change to very 
flattened epithelial morphology (for photograph, see reference 
44) and increased anchorage dependence which prevents the 
cells piling up on top of each other, and this is reflected in 
the much lower cell number at saturation density. (b) After 2 
wk of androgen deprivation in stock cultures, the saturation 
density in the presence of testosterone dropped (Fig.  2).  At 
this stage, the cells lost their ability to revert to the fibroblastic 
morphology after  1 wk in  the  presence of testosterone.  (c) 
After 3-14 wk of androgen withdrawal in stock cultures, the 
cells now grew to lower saturation density in the presence of 
testosterone than in its absence (Fig. 2). The stock androgen- 
depleted cells maintained an epithelial morphology through- 
out but changed from a  circular to a  more elongated form. 
The elongated cells packed together more closely into an even 
monolayer than the circular ceils and grew to higher saturation 
densities. After 1 wk in the presence of testosterone, the cells 
were of the circular epithelial form and grew to lower satura- 
tion density than in the absence of testosterone where all cells 
were of the elongated form. (d) After even longer periods of 
androgen withdrawal in stock cultures, saturation density of 
the  cells both  in  the  presence and  absence of testosterone 
increased, such that after 20 wk of androgen deprivation, the 
cells had lost all androgen responsiveness in terms of satura- 
tion density (Fig. 2). No further morphological changes were 
observed. The cells grew in  elongated form in  well-packed 
even monolayer under all androgen conditions. 
These four stages in the loss of androgen responsiveness 
can be seen clearly in Fig. 3, as the ratio of saturation densities 
in  the  presence  and  absence  of testosterone.  Attempts  to 
reverse these events are also shown in Fig. 3. Cells grown for 
6  wk  in  the  absence  of testosterone  followed by 6  wk  in 
testosterone-supplemented medium reattained full androgen 
responsiveness and grew as original +A cells. The longer the 
cells were maintained without androgen, the longer it took to 
reverse the process and it may be that once the ceils become 45- 
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FIGURE 3  LOSS  and  recovery of  saturation  density  response  in 
monolayer culture after  long-term withdrawal and  readdition of 
androgen in stock cultures.  Results are expressed as ratios of cell 
numbers  per  dish  in  the  short-term  presence  and  absence  of 
testosterone,  following either androgen withdrawal H)  from 
stock  cultures,  or  androgen withdrawal and  then  readdition of 
testosterone (FI- -  -FI) in stock cultures.  Arrows indicate the times 
at which testosterone was readded to stock cultures. 
terone for 20 wk were tested after 24 h with (a) readdition of 
testosterone and (b) readdition of dexamethasone (10  -7 M). 
In neither case was any MMTV-LTR-related RNA recovered 
(data not shown). 
O N A  M E T n  V L A T l O N :  Methylation patterns of MMTV- 
LTR-related sequences in the DNA of the cloned +A S115 
cells  were characterized during a  period of androgen  with- 
drawal (Fig.  5). This was done using the isoschizomeric re- 
striction enzymes Hpa II and Msp I, which cut unmethylated 
DNA at the same sites but differ in their sensitivity to cytosine 
methylation (40).  Since androgen-maintained (+A+T) cells 
show different patterns with Hpa II and Msp I (Fig.  5), the 
LTR  sequences  of S115  +A  cells  are  methylated to  some 
extent. Comparison was then made to Hpa II/Msp I patterns 
of S 115 DNA after increasing periods of androgen withdrawal 
(Fig. 5). No differences from +A+T DNA were observed until 
13 wk of androgen deprivation, when small increases began 
in methylation ofHpa II-sensitive sites. By 28 wk of  androgen 
withdrawal, two of  the small Hpa II restriction fragments were 
totally missing and after 42 wk all Hpa II fragments below 4 
kilobase pairs, except one faint band, were lost. 
Reproducibility of these changes in methylation patterns of 
S115  +A  DNA  following  androgen  withdrawal  has  been 
established in two separate long-term experiments. 
fully  unresponsive  (-A  state)  at  greater  than  20  wk,  the 
process is irreversible by testosterone alone. Fully unrespon- 
sive -A cells were kept in androgen-containing medium for 
42  wk  and  reattained  no  responsiveness  at  all  (data  not 
shown). 
Reproducibility of the time course of these events of loss of 
response has been demonstrated in two separate experiments 
and also in previous [3H]thymidine labeling studies (3). 
Molecular Events 
M  MTV  aN A  :  The  types  of MMTV-LTR-related  RNA 
produced in androgen-maintained +A S 115 cells have been 
described previously (6)  and are regulated within  hours by 
testosterone  (Darbre,  manuscript  in  preparation).  A  time 
course  of loss  of these  RNAs  during  long-term  androgen 
withdrawal revealed total loss after 9 wk (Fig.  4, lanes 1-8). 
MMTV-LTR-related RNA  was recovered by readdition  of 
testosterone  for  1  wk  in  cells  that  had  been  deprived  of 
testosterone for 6 wk (Fig. 4, lanes 4, 9, and 10), 12 wk (Fig. 
4, lanes 11-14),  or 18 wk (Fig. 4, lanes 15-19).  Recovery was 
mainly of the 16S RNA, but this may be a detection problem 
in that the  16S  RNA is the major species present. After 34 
wk of androgen  deprivation, no MMTV-LTR-related RNA 
was recovered in  the  cells even after  8  wk  of testosterone 
readdition (Fig.  4,  tracks 20-23).  In a  separate experiment, 
fully androgen unresponsive -A cells were kept in androgen- 
supplemented medium for 42 wk, and although no recovery 
of androgen-responsive cell biology was attained (see earlier), 
no MMTV-LTR-RNA was recovered either (data not shown). 
Dexamethasone also regulates these MMTV-LTR-related 
RNAs in the short-term in S 115 cells (reference 6 and Darbre, 
manuscript in preparation), and this response is also lost after 
long-term androgen deprivation. Cells grown without testos- 
FIGURE 4  Analysis of MMTV-LTR-related  RNA in cloned +A S115 
cells  after various  periods of testosterone withdrawal (-T)  and 
readdition (+T) as indicated. Total cytoplasmic RNA was loaded at 
50 #g per lane and autoradiography was for 96 h.  Photographic 
reduction is 91.6%. 
FIGURE 5  Restriction endonuclease  analysis of MMTV-LTR-related 
sequences in the DNA of cloned +A $I 15 cells following increasing 
periods of androgen withdrawal (-T).  DNA was either undigested 
(X) or digested with Hpa II (H) or Msp I (M) and blots were probed 
with ~2P-labeled  MMTV-LTR. Molecular weight standards were pro- 
vided  by  a  Hind  III  digest  of  bacteriophage X  DNA  and  their 
positions are indicated by horizontal arrows.  Photographic  reduc- 
tion is 91.7%. 
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unresponsive -A cells put back on androgens for 20 wk was 
also assessed.  These studies were carded out in parallel with 
attempts to recover androgen-sensitive MMTV-RNA and cell 
biological  parameters.  Readdition  of testosterone  did  not 
result in any decrease in methylation (data not shown). 
DISCUSSION 
We have described here detailed time courses of some cellular 
and molecular changes during the loss of steroid hormone 
sensitivity of cells.  Growth  of cloned  androgen-responsive 
(+A) S 115 cells in the prolonged absence of androgen resulted 
reproducibly in the loss of several hormone-sensitive param- 
eters. Proliferative response was lost after 9 wk of androgen 
withdrawal, but loss of saturation density response, cell mor- 
phology response, and MMTV-LTR-related RNA all took at 
least 20 wk of androgen deprivation. The data demonstrate 
that in a cloned hormone-responsive cell line, the transition 
to steroid autonomy can involve an ordered series of pheno- 
typic changes which are reversible for a certain length of  time. 
These changes cannot be explained by loss of  receptor because 
S I 15  cells possess androgen receptors in both +A and  -A 
states (3, 28). 
Tumors, although monoclonal in origin, acquire marked 
heterogeneity in cell type (see the beginning of this article). 
Any studies that investigate the origin of tumor heterogeneity 
are difficult to perform because response to any stimulus in 
vivo may result from changes in the relative proportions of 
subpopulations of cells, and the same argument can be used 
of an established cell line in which all cells are not identical. 
Indeed, both the Shionogi tumor (31) and the initial S115 cell 
line  (3)  were  composed of subpopulations of androgen-re- 
sponsive and  -unresponsive cells.  Use of cloned  androgen- 
responsive S115  cells in these experiments has shown that a 
population of unresponsive cells can be reproducibly obtained 
from a clone of responsive cells when deprived of hormone 
in the  long-term. The reproducibility of these experiments 
with  cloned  ceils  suggests  that  selection  of genotypically 
changed (mutated) ceils is unlikely to be involved. Alterations 
along the time course of loss of hormone-sensitive parameters 
are ordered and begin within 2 wk. It would be unlikely for 
identical mutations to occur always within such a short length 
of  time. Furthermore, at least one of  these phenotypic changes 
(loss of MMTV-RNA) is not accompanied by gross genetic 
alterations (6). 
This suggests,  then, that progression to steroid autonomy 
may be phenotypic, but the involvement of cell selection in 
the process will need further study. Cell selection is unlikely 
to be involved in the cell morphology changes because they 
are so ordered and uniform. Subpopulations of fibroblastic, 
circular epithelial, and elongated epithelial cells are not seen 
under the microscope. Monoclonal cell selection cannot ex- 
plain the  recovery of MMTV-LTR-RNA. MMTV-LTR-re- 
lated  RNA  can  be  recovered after  1 wk  of readdition  of 
testosterone. During this 1 wk recovery period, the cells grow 
more slowly and to lower saturation density in the presence 
than in the absence of testosterone. It would not be possible 
for cells that grow more slowly to outgrow a  population of 
cells within  1 wk. However, the general heterogeneity of the 
response will require further experiments. 
After  20  wk  of androgen  deprivation,  the  cells  became 
androgen insensitive (-A state) in terms of cell proliferation, 
cell morphology, and MMTV-LTR-RNA production. At this 
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stage,  reversal to an  androgen-sensitive state has  not  been 
achieved with respect to any of these three parameters. It is 
interesting to note that the time at which the cells lose response 
to androgen corresponds to the time at which methylation 
increases  in  LTR  sequences  of the  DNA.  Since  no  total 
methylation of Hpa II-sensitive sites was detected until 28 wk 
of androgen  deprivation,  DNA  methylation cannot  be  in- 
volved in initial loss of the androgen-sensitive MMTV-RNA 
production. However, methylation could be involved in final 
irreversible steps towards androgen insensitivity. But whether 
it is a direct ultimate control mechanism or merely a conse- 
quence of  long-term lack of  expression remains unclear. DNA 
methylation has been implicated in eucaryotic gene expres- 
sion (1,  13,  17,  34),  in control of MMTV expression (4),  in 
tumorigenesis in mice (2,  14,  15), in human cancer (12,  16, 
20), and in tumor progression to steroid insensitivity (6, 21). 
Our data presented here lend  further support to this latter 
hypothesis. 
These  data  suggest,  then,  that  progression  to  hormone 
insensitivity involves an ordered series of phenotypic changes, 
which can be reversed up to the time at which the cells lose 
all cell biological response to androgen and increases in DNA 
methylation  of MMTV-LTR  sequences  are  detected.  The 
extent of the DNA methylation in the total genome of -A 
cells will now be a subject for further study. 
Received  for publication  26 March 1984, and in revised form 18 June 
1984. 
REFERENCES 
1.  Bird, A. P. 1984. DNA methylation--how important in gene control? Nature (Lond.). 
307:503-504. 
2.  Breznik, T., and J. C. Cohen.  1982. Altered methylation of endngenous viral promoter 
sequences during mammary carcinogenesis.  Nature (Lond.).  295:255-257. 
3.  Cambmy, G. J.  1979.  Steroidal  control of a  mammary turnout cell line.  PhD Thesis. 
University of London, England., 
4.  Cohen,  J.  C.  1980.  Methylation  of milk-borne  and  genetically  transmitted  mouse 
mammary turnout virus proviral DNA. Cell.  19:653--662. 
5.  Couchman,  J.  R.,  J.  Yates,  R.  J.  B.  King, and  R.  A.  Badley.  1981.  Changes in 
microfdament and focal adhesion distribution with ioss of androgen responsiveness in 
cultured mammary turnout ceils. Cancer Res. 41:263-269. 
6.  Darbre, P., C. Dickson, G. Peters, M. Page, S. Curtis, and R. J. B. King. t983. Androgen 
regulation of cell proliferation and expression of viral sequences in mouse mammary 
tumour cells. Nature (Lond.). 303:431--433. 
7.  Darbre, P., J. Yates, S. Curtis, and R. J. B. King. 1983. Effect of estradiol on human 
breast cancer cells in culture. Cancer Res. 43:349-354. 
8.  Desmond, W. J., S. J. Wolbers, and G. Satu.  1976. Cloned mouse mammary cell fines 
requiring androgens for growth in culture. Cell. 8:79-86. 
9.  De  Sombre,  E.  R.,  and  E.  V. Jensen.  1982.  Clinical  usefulness of steroid  receptor 
determinations in breast cancer. In Hormonal Regulation of Mammary Tumors, Vol. 
1. B. S. Leung, editur. Eden Press Inc., Montreal, Canada. 155-182. 
10.  Dexter, D. L., and P. Calabresi.  1982. Intraneoplastic diversity. Biochim.  Biophys.  Acta. 
695:97-112. 
11.  Dexter, D. L., H. M. Kowalski, B. A. Blazar,  Z. Fligiel,  R. Vogel,  and G. Heppner. 
1978. Heterogeneity of tumor cells from a tingle mouse mammary tumor. Cancer Res. 
38:3174-3181. 
12.  Diala, E. S.,  M. S. C. Cheah,  D. Rowiteh, and R. M. Hoffman.  1983. The extent of 
DNA methylation in human tumor cells. J. Natl.  Cancer Inst.  71:755-764. 
13.  Doerfler, W.  1983.  DNA methylation and gene activity. Annu.  Rev. Biochem.  52:93- 
124. 
14.  Drohan, W. N., L. E. Benado, D. E. Graham, and G. H. Smith. 1982. Mouse mammary 
tumor virus proviral sequences congenital to C3H/Sm mice are differentially hypometh- 
ylated in chemically induced,  virus-induced and  spontaneous  mammary tumors.  Z 
ViroL 43:876-884. 
15.  Fanning, T. G., A. B. Vassos,  and R. D. Cardiff. 1982. Mcthylation and amplification 
of mouse mammary tumor virus DNA in normal, premalignant, and malignant cells of 
GR/A mice. J.  Virol. 41:1007-1013. 
16.  Feinberg, A. P., and B. Vngelstein.  1983. Hypomethylalion distinguishes genes of some 
human cancers from their normal counterparts. Nature (Lond.).  301:89-92. 
17.  Felsenfeid,  G., and J. McGhee.  1982.  Methylation and gene control.  Nature (Lond.). 
296:602-603. 
18.  Fidler, I. J., and t. R. Hart. 1981. The origin of metastatic heterogeneity in tumors. Eur. 
J. Cancer.  17:487--494. 
19.  Foulds, L. 1969. In Neoplastic Development, Vol.  i. Academic Press, Inc., New York. 
54-56. 
20.  Gama-sosa, M. A.,  V. A. Slagel,  IL W. Trewyn, R. Oxenhandler,  K. C. Kuo, C. W. 
Gehrke, and M. Ehdich.  1983.  The 5-methyl-eytusine  content of DNA from human 
tumors. Nucleic  Acids Res.  I 1:6883--6894. 
21.  Gasson, J. C., T. Ryden, and S. Bourgeois.  1983. Role of de novo DNA methylation in 
the glucoeorticoid resistance of a T-lymphoid cell line. Nature (Lond.).  302:621--623. 22.  Hager, J.  C.,  S.  Fligiel,  W.  Stanley,  A.  M.  Richardson,  and G.  H.  Heppner.  1981. 
Characterization  of a  variant-producing tumor cell  line from a  heterogeneous grain 
BALB/cfC3H mouse mammary tumor. Cancer Res. 41:1293-1300. 
23.  Heppner,  G.  H.,  D.  L.  Dexter,  T.  DeNucci,  F.  R.  Miller,  and  P.  Calabresi.  1978. 
Heterogeneity in drug sensitivity among tumor cell subpopulations of  a single mammary 
tumor. Cancer Res. 38:3758-3763. 
24.  Kerbel, R. S.  1979.  Implications of immunological heterogeneity of turnouts.  Nature 
(Loud.).  280:358-360. 
25.  Kim, U., and M. J. Depowski. 1975. Progression from hormone dependence to auton- 
omy in mammary tumors as in vivo manifestation of sequential clonal selection.  Cancer 
Res. 35:2068-2077. 
26.  King. R. J. B. 1979. How important are steroids in regulating the growth of mammary 
tumors? Biochem.  Actions Hormones. 6:247-265. 
27.  King, R. J. B., G. J. Cambray, R. Jagus-Smith, J. H. Robinson, and J. A. Smith. 1976. 
Steroid hormones and the control  of tumor growth: studies on andrngen-responsive 
tumor  cells  in  culture.  In  Receptors  and  Mechanisms of Steroid  Hormones.  J.  R. 
Pasqualinl, editor. Marcel Dekker, Inc., New York. 215-261. 
28.  King, R. J. B., G. J. Cambray, and J. H. Robinson.  1976. The rule of receptors in the 
steroidal regulation of tumour cell proliferation.  J. Steroid Biochem.  7:869-873. 
29.  Leung. B. S., editor.  1982. Hormonal Regulation of Mammary Turnouts, Vol. I & II. 
Eden Press, Montreal, Canada. 
30.  Maniatis, T., E. F. Fritsch, and J. Sambrook.  1982.  Molecular Cloning: a Laboratu~ 
Manual. Cold Spring Harbor Laboratory, New York. 
31.  Matsumoto, K., B. Sato, and Y. Kitamura.  1982. Roles of andrngen and its receptors 
in mouse mammary tumor. In Hormonal Regulation of Mammary Tumors, Vol. I. B. 
S. Leung, editor. Eden Press, Montreal, Canada. 216-244. 
32.  Michalides, R., E. Wageoaar, and M. Sluyser.  1982. Mammary tumor virus DNA as a 
marker for genotypic variance  within hormone-responsive GR mouse mammary  tumors. 
Cancer Res. 42:1154-1158. 
33.  Pellicer,  A.,  M.  Wigler,  R.  Axel,  and  S.  Silverstcin.  1978.  The  transfer and  stable 
integration of the HSV thymidine kinase gene into mouse cells. Cell.  14:133-14 I. 
34.  Razin, A., and A. D. Riggs. 1980. DNA methylation and gene function. Science(Wash. 
DC). 210:604-610. 
35.  Sluyser,  M.  1981.  Hormone  receptors  in  mouse  mammary tumors.  In  Mammary 
Tumors  in  the  Mouse.  J.  Hilgets and  M.  Sluyser,  editors.  Elsevier/North  Holland 
Biomedical Press, Amsterdam. 267-299. 
36.  Sluyser,  M.,  C.  C.  J.  De Goeij,  and  S.  G.  Evers.  1981.  Changes in  sensitivity to 
cyclophosohamide of mouse mammary tumors during serial transplantation.  J. Natl. 
Cancer Inst.  66:327-330. 
37.  Smith, J. A., and R. J. B. King. 1972.  Effects of steroids on growth of an androgen- 
deoendant mouse mammary carcinoma in cell culture. Exp. CellRes. 73:351-359. 
38.  Soule,  H. D., T. Maloney, and C. M. McGrath.  1981. Pllenotylfic  variance among cells 
isolated  from spontaneous  mouse mammary tumors in primary suspension culture. 
Cancer Res. 41:1154-1164. 
39.  Stanley,  E. R.,  R. E. Palmer, and U. Sohn.  1977.  Development of methods for the 
quantitative in vitro analysis of andrngen-de0endent and autonomous Shionogi carci- 
noma 115 cells. Cell.  10:35--44. 
40.  Waalwijk, C., and R. A. Flavell.  1978. DNA methylation at a CCGG sequence in the 
large intron  of the rabbit #-globin gene: tissue specific variations. Nucleic Acids Res. 
5:4631--4641. 
41.  Wigler, M., R. Sweet, G. K. Sire, B. Wold, A. Pellicer,  E. Lacy, T. Manlatis, S. Silverstein, 
and R. Axel.  1979.  Transformation of mammalian cells with genes from procaryotes 
and eucaryotes. Cell.  16:777-785. 
42.  Yates, J.,  J.  R.  Couchman,  and R.  J.  B.  King.  1980.  Androgen  effects on growth, 
morphology,  and  sensitivity of S115  mouse  mammary tumor  cells  in  culture.  In 
Hormones and Cancer. Progress in Cancer Research and Therapy. S. Iacobelli,  R. J. B. 
King, H. R. Linduer, M. E. Lippman, editors. Raven Press, New York. 14:31-39. 
43.  Yates, J., and R. J.  B. King. 1978.  Multiple sensitivities of mammary tumor cells in 
culture.  Cancer Res. 38:4135--4137. 
44.  Yates, J., and R. J. B. King. 1981.  Correlation of gruwth properties and morphology 
with hormone responsiveness of mammary tumor cells in culture. Cancer Res. 41:258- 
262. 
D^ReRE AnD  KinG  Androgen Sensitivity of Mammary Tumor Cells  141 5 